RESULTS IN ALL CASES OF CANCER
|
| Response |
Number |
Percent |
|
| Complete Regression (C-R) |
31 / 254 |
12.2 % |
| Partial Regression (P-R) |
103 / 254 |
40.6% |
| Minor Response (M-R) |
33 / 254 |
12.9 % |
| Stable Disease (S-D) |
34 / 254 |
13.4 % |
| Progression (PROGR.) |
26 / 254 |
10.2 % |
| Treatment not started (T-N-S) |
27 / 254 |
10.7 % |
|
RESULTS IN OVARIAN CARCINOMA PATIENTS
|
| Response |
Percent |
|
| Complete Regression (C-R) |
10.9 % |
| Partial Regression (P-R) |
41.3 % |
| Minor Response (M-R) |
10.7 % |
| Stable Disease (S-D) |
17.8 % |
| Progression (PROGR.) |
5.8 % |
| Treatment not started (T-N-S) |
13.5 % |
|
RESULTS IN BREAST CANCER PATIENTS
|
| Response |
Percent |
|
| Complete Regression (C-R) |
13.8 % |
| Partial Regression (P-R) |
48.2 % |
| Minor Response (M-R) |
13.6 % |
| Stable Disease (S-D) |
10.4 % |
| Progression (PROGR.) |
9.2% |
| Treatment not started (T-N-S) |
4.8 % |
|
RESULTS IN COLORECTAL CANCER PATIENTS
|
| Response |
Percent |
|
| Complete Regression (C-R) |
8.7 % |
| Partial Regression (P-R) |
21.2 % |
| Minor Response (M-R) |
12.3 % |
| Stable Disease (S-D) |
15.3 % |
| Progression (PROGR.) |
30.3 % |
| Treatment not started (T-N-S) |
12.2 % |
|
RESPONSE IN BRONCHIAL CARCINOMA PATIENTS
|
| Response |
Percent |
|
| Complete Regression (C-R) |
10.3 % |
| Partial Regression (P-R) |
65.8 % |
| Minor Response (M-R) |
6.2 % |
| Stable Disease (S-D) |
5.3 % |
| Progression (PROGR.) |
3.1% |
| Treatment not started (T-N-S) |
9.3 % |
|
RESPONSE IN PANCREATIC CARCINOMA PATIENTS
|
| Response |
Percent |
|
| Complete Regression (C-R) |
17.3 % |
| Partial Regression (P-R) |
31.4 % |
| Minor Response (M-R) |
11.2 % |
| Stable Disease (S-D) |
17.9 % |
| Progression (PROGR.) |
8.7 % |
| Treatment not started (T-N-S) |
13.5 % |
|
|
